Sign in to view content

Evaluation of 8 mg Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration: Results from the Phase 2 CANDELA Study

W. Lloyd Clark, MD, FASRS

Video
Published 2022

Related

Avacincaptad Pegol, A Novel C5 Inhibitor, Demonstrates Continued Reduction in Geographic Atrophy Growth: 18-Month Results From GATHER1 Clinical Trial
Jason Hsu, MD
Annual Meeting Talks
2021
Outcomes of Anti-VEGF Treatment for CNV in Fellow Eyes of Previously Treated Patients with Wet AMD
Tarek S. Hassan, MD, FASRS
Updates from the Field
2019
Staring a Clinical Trials Program
David A. Eichenbaum, MD, FASRS
Updates from the Field
2019

Category: wet AMD

See more